Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2022 Volume 24 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2022 Volume 24 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Neuroprotective effects of CysLTR antagonist on Streptococcus pneumoniae‑induced meningitis in rats

  • Authors:
    • Shuying Yu
    • Xiaojin Chen
    • Xiaoyu Li
    • Jun Yan
    • Yingying Jiang
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacy, Hangzhou Children's Hospital, Hangzhou, Zhejiang 310014, P.R. China
    Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 443
    |
    Published online on: May 13, 2022
       https://doi.org/10.3892/etm.2022.11370
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Cysteinyl leukotrienes (CysLTs) modulate central nervous system inflammatory responses via their receptors, CysLT1R and CysLT2R. It has been demonstrated that CysLTR participates in the infection process of Streptococcus pneumoniae (SP)‑induced meningitis. In the present study, the effects and possible underlying mechanisms of CysLTR antagonists (pranlukast and HAMI 3379) on SP meningitis were further determined. SP meningitis was induced by intracerebroventricular injection of serotype III SP in Sprague‑Dawley rats which were administrated intraperitoneally with 0.1 mg/kg antagonists. The clinical disease status of rats was evaluated by body weight and behavioral changes with neurological scoring. Survival neuron density, activated microglial and astrocytes were assessed by Nissl staining and immunohistochemical staining. The expression levels of inflammatory cytokines and NLRP3 inflammasome were detected by reverse transcription‑quantitative PCR and western blotting, respectively. Pranlukast and HAMI 3379 treatment markedly alleviated the clinical disease status, which was manifested by improving body weight loss and neurological deficit. Furthermore, pranlukast and HAMI 3379 treatment ameliorated neuronal injury and inhibited microgliosis and astrogliosis. In addition, significant downregulation of inflammatory cytokines and NLRP3 expression was observed in pranlukast and HAMI 3379‑treated rats. These in vivo findings indicated the neuroprotective effects of CysLTR antagonists against experimental SP‑induced meningitis, and the mechanism of anti‑inflammatory effects may partly be by inhibiting NLRP3 inflammasome overactivation.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Li Y, Yin Z, Shao Z, Li M, Liang X, Sandhu HS, Hadler SC, Li J, Sun Y, Li J, et al: Population-based surveillance for bacterial meningitis in China, September 2006-December 2009. Emerg Infect Dis. 20:61–69. 2014.PubMed/NCBI View Article : Google Scholar

2 

Brouwer MC and van de Beek D: Epidemiology of community-acquired bacterial meningitis. Curr Opin Infect Dis. 31:78–84. 2018.PubMed/NCBI View Article : Google Scholar

3 

Edmond K, Scott S, Korczak V, Ward C, Sanderson C, Theodoratou E, Clark A, Griffiths U, Rudan I and Campbell H: Long term sequelae from childhood pneumonia; systematic review and meta-analysis. PLoS One. 7(e31239)2012.PubMed/NCBI View Article : Google Scholar

4 

Oldekamp S, Pscheidl S, Kress E, Soehnlein O, Jansen S, Pufe T, Wang JM, Tauber SC and Brandenburg LO: Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis. Immunology. 143:447–461. 2014.PubMed/NCBI View Article : Google Scholar

5 

Geldhoff M, Mook-Kanamori BB, Brouwer MC, Troost D, Leemans JC, Flavell RA, Van der Ende A, Van der Poll T and Van de Beek D: Inflammasome activation mediates inflammation and outcome in humans and mice with pneumococcal meningitis. BMC Infect Dis. 13(358)2013.PubMed/NCBI View Article : Google Scholar

6 

Wang G, Fu Y, Ma K, Liu J and Liu X: NOD2 regulates microglial inflammation through the TAK1-NF-κB pathway and autophagy activation in murine pneumococcal meningitis. Brain Res Bull. 158:20–30. 2020.PubMed/NCBI View Article : Google Scholar

7 

Bäck M, Dahlén SE, Drazen JM, Evans JF, Serhan CN, Shimizu T, Yokomizo T and Rovati GE: International union of basic and clinical pharmacology. LXXXIV: Leukotriene receptor nomenclature, distribution, and pathophysiological functions. Pharmacol Rev. 63:539–584. 2011.PubMed/NCBI View Article : Google Scholar

8 

Singh R, Gupta S, Dastidar S and Ray A: Cysteinyl leukotrienes and their receptors: Molecular and functional characteristics. Pharmacology. 85:336–349. 2010.PubMed/NCBI View Article : Google Scholar

9 

Takahashi Y, Imai K, Ikeda H, Kubota Y, Yamazaki E and Susa F: Open study of pranlukast add-on therapy in intractable partial epilepsy. Brain Dev. 35:236–244. 2013.PubMed/NCBI View Article : Google Scholar

10 

Zhu L, Maruvada R, Sapirstein A, Malik KU, Peters-Golden M and Kim KS: Arachidonic acid metabolism regulates Escherichia coli penetration of the blood-brain barrier. Infect Immun. 78:4302–4310. 2010.PubMed/NCBI View Article : Google Scholar

11 

Maruvada R, Zhu L, Pearce D, Zheng Y, Perfect J, Kwon-Chung KJ and Kim KS: Cryptococcus neoformans phospholipase B1 activates host cell Rac1 for traversal across the blood-brain barrier. Cell Microbiol. 14:1544–1553. 2012.PubMed/NCBI View Article : Google Scholar

12 

Zhu L, Maruvada R, Sapirstein A, Peters-Golden M and Kim K: Cysteinyl leukotrienes as novel host factors facilitating Cryptococcus neoformans penetration into the brain. Cell Microbiol 19: 10.1111/cmi.12661, 2017.

13 

Yu S, Yan J, Chen X, Zhu X, Li X and Liao L: Expression of cysteinyl leukotriene receptor in brain tissues of rats with Streptococcus pneumoniae meningitis. Int J Clin Exp Pathol. 12:4242–4252. 2019.PubMed/NCBI

14 

Zhang Y, Liu X, Bai X, Lin Y, Li Z, Fu J, Li M, Zhao T, Yang H, Xu R, et al: Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis. J Pineal Res. 64:2018.PubMed/NCBI View Article : Google Scholar

15 

Kim J, Paton J, Briles D, Rhee D and Pyo S: Streptococcus pneumoniae induces pyroptosis through the regulation of autophagy in murine microglia. Oncotarget. 6:44161–44178. 2015.PubMed/NCBI View Article : Google Scholar

16 

Loeffler JM, Ringer R, Hablutzel M, Tauber MG and Leib SL: The free radical scavenger alpha-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis. J Infect Dis. 183:247–252. 2001.PubMed/NCBI View Article : Google Scholar

17 

Türeyen K, Vemuganti R, Sailor KA and Dempsey RJ: Infarct volume quantification in mouse focal cerebral ischemia: A comparison of triphenyltetrazolium chloride and cresyl violet staining techniques. J Neurosci Methods. 139:203–207. 2004.PubMed/NCBI View Article : Google Scholar

18 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

19 

Mostowy R, Croucher NJ, Hanage WP, Harris SR, Bentley S and Fraser C: Heterogeneity in the frequency and characteristics of homologous recombination in pneumococcal evolution. PLoS Genet. 10(e1004300)2014.PubMed/NCBI View Article : Google Scholar

20 

Pfister LA, Tureen JH, Shaw S, Christen S, Ferriero DM, Täuber MG and Leib SL: Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis. Ann Neurol. 47:329–335. 2000.PubMed/NCBI

21 

Förderreuther S, Tatsch K, Einhäupl KM and Pfister HW: Abnormalities of cerebral blood flow in the acute phase of bacterial meningitis in adults. J Neurol. 239:431–436. 1992.PubMed/NCBI View Article : Google Scholar

22 

Tureen JH, Täuber MG and Sande MA: Effect of hydration status on cerebral blood flow and cerebrospinal fluid lactic acidosis in rabbits with experimental meningitis. J Clin Invest. 89:947–953. 1992.PubMed/NCBI View Article : Google Scholar

23 

Pschibul A, Janzarik WG, Franck P, Hufnagel M, Beck C and Korinthenberg R: Cystic encephalomalacia following vasculopathy and vasospasm of proximal intracranial arteries due to pneumococcal meningitis in a infant. Neuropediatrics. 49:213–216. 2018.PubMed/NCBI View Article : Google Scholar

24 

Yu GL, Wei EQ, Wang ML, Zhang WP, Zhang SH, Weng JQ, Chu LS, Fang SH, Zhou Y, Chen Z, et al: Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice. Brain Res. 1053:116–125. 2005.PubMed/NCBI View Article : Google Scholar

25 

Shi QJ, Wang H, Liu ZX, Fang SH, Song XM, Lu YB, Zhang WP, Sa XY, Ying HZ and Wei EQ: HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats. Neuroscience. 291:53–69. 2015.PubMed/NCBI View Article : Google Scholar

26 

Leib SL, Kim YS, Chow LL, Sheldon RA and Täuber MG: Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J Clin Invest. 98:2632–2639. 1996.PubMed/NCBI View Article : Google Scholar

27 

Wellmer A, Noeske C, Gerber J, Munzel U and Nau R: Spatial memory and learning deficits after experimental pneumococcal meningitis in mice. Neurosci Lett. 296:137–140. 2000.PubMed/NCBI View Article : Google Scholar

28 

Zhu N, Liu W, Prakash A, Zhang C and Kim KS: Targeting E. coli invasion of the blood-brain barrier for investigating the pathogenesis and therapeutic development of E. coli meningitis. Cell Microbiol. 22(e13231)2020.PubMed/NCBI View Article : Google Scholar

29 

Zhang XY, Wang XR, Xu DM, Yu SY, Shi QJ, Zhang LH, Chen L, Fang SH, Lu YB, Zhang WP and Wei EQ: HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation. J Pharmacol Exp Ther. 346:328–341. 2013.PubMed/NCBI View Article : Google Scholar

30 

Ramesh G, MacLean A and Philipp M: Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. 2013(480739)2013.PubMed/NCBI View Article : Google Scholar

31 

Liu X, Chauhan VS, Young AB and Marriott I: NOD2 mediates inflammatory responses of primary murine glia to Streptococcus pneumoniae. Glia. 58:839–847. 2010.PubMed/NCBI View Article : Google Scholar

32 

Giridharan VV, Collodel A, Generoso JS, Scaini G, Wassather R, Selvaraj S, Hasbun R, Dal-Pizzol F, Petronilho F and Barichello T: Neuroinflammation trajectories precede cognitive impairment after experimental meningitis-evidence from an in vivo PET study. J Neuroinflammation. 17(5)2020.PubMed/NCBI View Article : Google Scholar

33 

Zhang D, Hu X, Qian L, O'Callaghan JP and Hong JS: Astrogliosis in CNS pathologies: Is there a role for microglia? Mol Neurobiol. 41:232–241. 2010.PubMed/NCBI View Article : Google Scholar

34 

Rohl C, Lucius R and Sievers J: The effect of activated microglia on astrogliosis parameters in astrocyte cultures. Brain Res. 1129:43–52. 2007.PubMed/NCBI View Article : Google Scholar

35 

Fang SH, Wei EQ, Zhou Y, Wang ML, Zhang WP, Yu GL, Chu LS and Chen Z: Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats. Neuroscience. 140:969–979. 2006.PubMed/NCBI View Article : Google Scholar

36 

Fang SH, Zhou Y, Chu LS, Zhang WP, Wang ML, Yu GL, Peng F and Wei EQ: Spatio-temporal expression of cysteinyl leukotriene receptor-2 mRNA in rat brain after focal cerebral ischemia. Neurosci Lett. 412:78–83. 2007.PubMed/NCBI View Article : Google Scholar

37 

Zhao CZ, Zhao B, Zhang XY, Huang XQ, Shi WZ, Liu HL, Fang SH, Lu YB, Zhang WP, Tang FD and Wei EQ: Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats. Neuroscience. 189:1–11. 2011.PubMed/NCBI View Article : Google Scholar

38 

Mitchell AJ, Yau B, McQuillan JA, Ball HJ, Too LK, Abtin A, Hertzog P, Leib SL, Jones CA, Gerega SK, et al: Inflammasome-dependent IFN-γ drives pathogenesis in Streptococcus pneumoniae meningitis. J Immunol. 189:4970–4980. 2012.PubMed/NCBI View Article : Google Scholar

39 

Matsuse H, Kondo Y, Machida I, Kawano T, Saeki S, Tomari S, Obase Y, Fukushima C, Mizuta Y and Kohno S: Effects of anti-inflammatory therapies on recurrent and low-grade respiratory syncytial virus infections in a murine model of asthma. Ann Allergy Asthma Immunol. 97:55–60. 2006.PubMed/NCBI View Article : Google Scholar

40 

Fujii M, Tanaka H and Abe S: Interferon-gamma up-regulates expression of cysteinyl leukotriene type 2 receptors on eosinophils in asthmatic patients. Chest. 128:3148–3155. 2005.PubMed/NCBI View Article : Google Scholar

41 

Liu Y, Duan C, Chen H, Wang C, Liu X, Qiu M, Tang H, Zhang F, Zhou X and Yang J: Inhibition of COX-2/mPGES-1 and 5-LOX in macrophages by leonurine ameliorates monosodium urate crystal-induced inflammation. Toxicol Appl Pharmacol. 351:1–11. 2018.PubMed/NCBI View Article : Google Scholar

42 

Amaral FA, Costa VV, Tavares LD, Sachs D, Coelho FM, Fagundes CT, Soriani FM, Silveira TN, Cunha LD, Zamboni DS, et al: NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout. Arthritis Rheum. 64:474–484. 2012.PubMed/NCBI View Article : Google Scholar

43 

Zhang W, Ba G, Tang R, Li M and Lin H: Ameliorative effect of selective NLRP3 inflammasome inhibitor MCC950 in an ovalbumin-induced allergic rhinitis murine model. Int Immunopharmacol. 83(106394)2020.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yu S, Chen X, Li X, Yan J and Jiang Y: Neuroprotective effects of CysLTR antagonist on <em>Streptococcus pneumoniae</em>‑induced meningitis in rats. Exp Ther Med 24: 443, 2022.
APA
Yu, S., Chen, X., Li, X., Yan, J., & Jiang, Y. (2022). Neuroprotective effects of CysLTR antagonist on <em>Streptococcus pneumoniae</em>‑induced meningitis in rats. Experimental and Therapeutic Medicine, 24, 443. https://doi.org/10.3892/etm.2022.11370
MLA
Yu, S., Chen, X., Li, X., Yan, J., Jiang, Y."Neuroprotective effects of CysLTR antagonist on <em>Streptococcus pneumoniae</em>‑induced meningitis in rats". Experimental and Therapeutic Medicine 24.1 (2022): 443.
Chicago
Yu, S., Chen, X., Li, X., Yan, J., Jiang, Y."Neuroprotective effects of CysLTR antagonist on <em>Streptococcus pneumoniae</em>‑induced meningitis in rats". Experimental and Therapeutic Medicine 24, no. 1 (2022): 443. https://doi.org/10.3892/etm.2022.11370
Copy and paste a formatted citation
x
Spandidos Publications style
Yu S, Chen X, Li X, Yan J and Jiang Y: Neuroprotective effects of CysLTR antagonist on <em>Streptococcus pneumoniae</em>‑induced meningitis in rats. Exp Ther Med 24: 443, 2022.
APA
Yu, S., Chen, X., Li, X., Yan, J., & Jiang, Y. (2022). Neuroprotective effects of CysLTR antagonist on <em>Streptococcus pneumoniae</em>‑induced meningitis in rats. Experimental and Therapeutic Medicine, 24, 443. https://doi.org/10.3892/etm.2022.11370
MLA
Yu, S., Chen, X., Li, X., Yan, J., Jiang, Y."Neuroprotective effects of CysLTR antagonist on <em>Streptococcus pneumoniae</em>‑induced meningitis in rats". Experimental and Therapeutic Medicine 24.1 (2022): 443.
Chicago
Yu, S., Chen, X., Li, X., Yan, J., Jiang, Y."Neuroprotective effects of CysLTR antagonist on <em>Streptococcus pneumoniae</em>‑induced meningitis in rats". Experimental and Therapeutic Medicine 24, no. 1 (2022): 443. https://doi.org/10.3892/etm.2022.11370
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team